Frontage Laboratories Inc-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014371)
◆英語タイトル:Frontage Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014371
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Frontage Laboratories Inc (Frontage), a subsidiary of Hangzhou Tigermed Consulting Co Ltd is a contract research organization that offers early phase drug development and other research services. The organization’s services include clinical research, drug metabolism and pharmacokinetic, CMC services, bioanalytical, agrochemical services, and GMP consulting services. Its DMPK services include in vitro absorption, distribution, metabolism, and excretion studies, in vivo ADME studies, metabolite identification, non-GLP bioanalytical studies, radiolabeled studies and metabolites in safety testing for clinical compounds. Frontage’s CMC product development services includes organic synthesis, pharmaceutical formulation development, GMP analytical testing and GMP clinical trial material manufacturing. The organization caters to pharmaceutical and biotech companies. It has presence in China and the US. Frontage is headquartered in Exton, Pennsylvania, the US.

Frontage Laboratories Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Frontage Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Frontage Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Zhejiang Jiuzhou Pharma forms Joint Venture with Frontage Labs 10
Frontage Labs Partners Spaulding Clinical Research 11
Yabao Pharma Enters Into A Development Agreement With Frontage Labs 12
Acquisition 13
Hangzhou Tigermed Completes Acquisition of Majority Stake in Frontage Labs for USD50.2 Million 13
Frontage Laboratories Inc – Key Competitors 14
Frontage Laboratories Inc – Key Employees 15
Frontage Laboratories Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Recent Developments 18
Corporate Communications 18
Mar 15, 2017: Frontage Announces that Dr. Philip Doren has Joined Frontage as the President of Clinical Services 18
Legal and Regulatory 19
Jun 15, 2016: Frontage becomes the first CRO to complete GLP validation on Simoa HD-1 Analyzer for Biomarker Analysis 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts 2
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Frontage Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Frontage Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Frontage Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Zhejiang Jiuzhou Pharma forms Joint Venture with Frontage Labs 10
Frontage Labs Partners Spaulding Clinical Research 11
Yabao Pharma Enters Into A Development Agreement With Frontage Labs 12
Hangzhou Tigermed Completes Acquisition of Majority Stake in Frontage Labs for USD50.2 Million 13
Frontage Laboratories Inc, Key Competitors 14
Frontage Laboratories Inc, Key Employees 15
Frontage Laboratories Inc, Other Locations 16
Frontage Laboratories Inc, Subsidiaries 16
Frontage Laboratories Inc, Joint Venture 16

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Frontage Laboratories Inc-製薬・医療分野:企業M&A・提携分析(Frontage Laboratories Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆